Industry Research Reports
Home > Reports > Medical Devices & Consumables > Recombinant Human Serum Albumin(HSA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Recombinant Human Serum Albumin(HSA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-05-23
Pages: 130 Pages
Report ld: 4744041
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Recombinant Human Serum Albumin(HSA) Market Size(US$)
CAGR 2025-2031
10.5%
Market Size,2031
USD 217
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 119 million
Market Forecast in 2031(Value)
US$ 217 million
CAGR
10.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Recombinant Human Serum Albumin(HSA) was estimated to be worth US$ 102 million in 2024 and is forecast to a readjusted size of US$ 217 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Recombinant Human Serum Albumin(HSA) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
As the most abundant protein in human plasma, human serum albumin (HSA) is a transporter of hormones, lipids and other substances. Its main physiological function is to regulate plasma pH and maintain plasma osmotic pressure. Human serum albumin is a single-chain protein composed of 585 amino acids with a molecular weight of 66.5kDa.
Albumin can provide nitrogen and essential amino acids that are important for cell growth and help maintain osmotic pressure balance in the cell culture environment. In addition, albumin can also serve as a substrate for cell attachment, help stabilize pH, and even protect cells from stress and damage. Albumin is usually added to cell culture media at different concentrations - depending on the cell type and culture application. It can also serve as a carrier protein for hormones, vitamins and other growth factors. In addition, HSA can be used as a stabilizer and/or adjuvant in vaccines.
North American market for Recombinant Human Serum Albumin(HSA) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Human Serum Albumin(HSA) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Recombinant Human Serum Albumin(HSA) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Recombinant Human Serum Albumin(HSA) include Merck, MP Biomedicals, Proteintech, InVitria, Sino Biological, Reprokine, ACROBiosystems, Assay Genie, Cell Biologics, Sartorius AG, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin(HSA), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Human Serum Albumin(HSA) by region & country, by Type, and by Application.
The Recombinant Human Serum Albumin(HSA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin(HSA).
MARKET SEGMENTATION
By Company
- Merck
- MP Biomedicals
- Proteintech
- InVitria
- Sino Biological
- Reprokine
- ACROBiosystems
- Assay Genie
- Cell Biologics
- Sartorius AG
- Yeasen
- MedChemExpress
- Abcam
- Basic Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Yeast Expression System
- Mammalian Cell Expression System
- Plant Expression System
- Insect Cell Expression System
Segment by Application
- Biopharmaceuticals
- Cell Culture & Regenerative Medicine
- In Vitro Diagnostics
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant Human Serum Albumin(HSA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Recombinant Human Serum Albumin(HSA) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Recombinant Human Serum Albumin(HSA) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Recombinant Human Serum Albumin(HSA) Product Introduction
1.2 Global Recombinant Human Serum Albumin(HSA) Market Size Forecast
1.2.1 Global Recombinant Human Serum Albumin(HSA) Sales Value (2020-2031)
1.2.2 Global Recombinant Human Serum Albumin(HSA) Sales Volume (2020-2031)
1.2.3 Global Recombinant Human Serum Albumin(HSA) Sales Price (2020-2031)
1.3 Recombinant Human Serum Albumin(HSA) Market Trends & Drivers
1.3.1 Recombinant Human Serum Albumin(HSA) Industry Trends
1.3.2 Recombinant Human Serum Albumin(HSA) Market Drivers & Opportunity
1.3.3 Recombinant Human Serum Albumin(HSA) Market Challenges
1.3.4 Recombinant Human Serum Albumin(HSA) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Recombinant Human Serum Albumin(HSA) Players Revenue Ranking (2024)
2.2 Global Recombinant Human Serum Albumin(HSA) Revenue by Company (2020-2025)
2.3 Global Recombinant Human Serum Albumin(HSA) Players Sales Volume Ranking (2024)
2.4 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Company Players (2020-2025)
2.5 Global Recombinant Human Serum Albumin(HSA) Average Price by Company (2020-2025)
2.6 Key Manufacturers Recombinant Human Serum Albumin(HSA) Manufacturing Base and Headquarters
2.7 Key Manufacturers Recombinant Human Serum Albumin(HSA) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Human Serum Albumin(HSA)
2.9 Recombinant Human Serum Albumin(HSA) Market Competitive Analysis
2.9.1 Recombinant Human Serum Albumin(HSA) Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Serum Albumin(HSA) Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin(HSA) as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Yeast Expression System
3.1.2 Mammalian Cell Expression System
3.1.3 Plant Expression System
3.1.4 Insect Cell Expression System
3.2 Global Recombinant Human Serum Albumin(HSA) Sales Value by Type
3.2.1 Global Recombinant Human Serum Albumin(HSA) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Recombinant Human Serum Albumin(HSA) Sales Value, by Type (2020-2031)
3.2.3 Global Recombinant Human Serum Albumin(HSA) Sales Value, by Type (%) (2020-2031)
3.3 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Type
3.3.1 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Recombinant Human Serum Albumin(HSA) Sales Volume, by Type (2020-2031)
3.3.3 Global Recombinant Human Serum Albumin(HSA) Sales Volume, by Type (%) (2020-2031)
3.4 Global Recombinant Human Serum Albumin(HSA) Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceuticals
4.1.2 Cell Culture & Regenerative Medicine
4.1.3 In Vitro Diagnostics
4.1.4 Others
4.2 Global Recombinant Human Serum Albumin(HSA) Sales Value by Application
4.2.1 Global Recombinant Human Serum Albumin(HSA) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Recombinant Human Serum Albumin(HSA) Sales Value, by Application (2020-2031)
4.2.3 Global Recombinant Human Serum Albumin(HSA) Sales Value, by Application (%) (2020-2031)
4.3 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Application
4.3.1 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Recombinant Human Serum Albumin(HSA) Sales Volume, by Application (2020-2031)
4.3.3 Global Recombinant Human Serum Albumin(HSA) Sales Volume, by Application (%) (2020-2031)
4.4 Global Recombinant Human Serum Albumin(HSA) Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Recombinant Human Serum Albumin(HSA) Sales Value by Region
5.1.1 Global Recombinant Human Serum Albumin(HSA) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (2020-2025)
5.1.3 Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (2026-2031)
5.1.4 Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (%), (2020-2031)
5.2 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region
5.2.1 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (2020-2025)
5.2.3 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (2026-2031)
5.2.4 Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (%), (2020-2031)
5.3 Global Recombinant Human Serum Albumin(HSA) Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
5.4.2 North America Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
5.5.2 Europe Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
5.6.2 Asia Pacific Recombinant Human Serum Albumin(HSA) Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
5.7.2 South America Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
5.8.2 Middle East & Africa Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value and Sales Volume
6.2.1 Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.2.2 Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.3.2 United States Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.4.2 Europe Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.5.2 China Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.6.2 Japan Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.7.2 South Korea Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.8.2 Southeast Asia Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Recombinant Human Serum Albumin(HSA) Sales Value, 2020-2031
6.9.2 India Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Recombinant Human Serum Albumin(HSA) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Merck Recombinant Human Serum Albumin(HSA) Product Offerings
7.1.5 Merck Recent Development
7.2 MP Biomedicals
7.2.1 MP Biomedicals Company Information
7.2.2 MP Biomedicals Introduction and Business Overview
7.2.3 MP Biomedicals Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 MP Biomedicals Recombinant Human Serum Albumin(HSA) Product Offerings
7.2.5 MP Biomedicals Recent Development
7.3 Proteintech
7.3.1 Proteintech Company Information
7.3.2 Proteintech Introduction and Business Overview
7.3.3 Proteintech Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Proteintech Recombinant Human Serum Albumin(HSA) Product Offerings
7.3.5 Proteintech Recent Development
7.4 InVitria
7.4.1 InVitria Company Information
7.4.2 InVitria Introduction and Business Overview
7.4.3 InVitria Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 InVitria Recombinant Human Serum Albumin(HSA) Product Offerings
7.4.5 InVitria Recent Development
7.5 Sino Biological
7.5.1 Sino Biological Company Information
7.5.2 Sino Biological Introduction and Business Overview
7.5.3 Sino Biological Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sino Biological Recombinant Human Serum Albumin(HSA) Product Offerings
7.5.5 Sino Biological Recent Development
7.6 Reprokine
7.6.1 Reprokine Company Information
7.6.2 Reprokine Introduction and Business Overview
7.6.3 Reprokine Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Reprokine Recombinant Human Serum Albumin(HSA) Product Offerings
7.6.5 Reprokine Recent Development
7.7 ACROBiosystems
7.7.1 ACROBiosystems Company Information
7.7.2 ACROBiosystems Introduction and Business Overview
7.7.3 ACROBiosystems Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 ACROBiosystems Recombinant Human Serum Albumin(HSA) Product Offerings
7.7.5 ACROBiosystems Recent Development
7.8 Assay Genie
7.8.1 Assay Genie Company Information
7.8.2 Assay Genie Introduction and Business Overview
7.8.3 Assay Genie Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Assay Genie Recombinant Human Serum Albumin(HSA) Product Offerings
7.8.5 Assay Genie Recent Development
7.9 Cell Biologics
7.9.1 Cell Biologics Company Information
7.9.2 Cell Biologics Introduction and Business Overview
7.9.3 Cell Biologics Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Cell Biologics Recombinant Human Serum Albumin(HSA) Product Offerings
7.9.5 Cell Biologics Recent Development
7.10 Sartorius AG
7.10.1 Sartorius AG Company Information
7.10.2 Sartorius AG Introduction and Business Overview
7.10.3 Sartorius AG Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Sartorius AG Recombinant Human Serum Albumin(HSA) Product Offerings
7.10.5 Sartorius AG Recent Development
7.11 Yeasen
7.11.1 Yeasen Company Information
7.11.2 Yeasen Introduction and Business Overview
7.11.3 Yeasen Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Yeasen Recombinant Human Serum Albumin(HSA) Product Offerings
7.11.5 Yeasen Recent Development
7.12 MedChemExpress
7.12.1 MedChemExpress Company Information
7.12.2 MedChemExpress Introduction and Business Overview
7.12.3 MedChemExpress Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 MedChemExpress Recombinant Human Serum Albumin(HSA) Product Offerings
7.12.5 MedChemExpress Recent Development
7.13 Abcam
7.13.1 Abcam Company Information
7.13.2 Abcam Introduction and Business Overview
7.13.3 Abcam Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Abcam Recombinant Human Serum Albumin(HSA) Product Offerings
7.13.5 Abcam Recent Development
7.14 Basic Pharma
7.14.1 Basic Pharma Company Information
7.14.2 Basic Pharma Introduction and Business Overview
7.14.3 Basic Pharma Recombinant Human Serum Albumin(HSA) Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Basic Pharma Recombinant Human Serum Albumin(HSA) Product Offerings
7.14.5 Basic Pharma Recent Development
8 Industry Chain Analysis
8.1 Recombinant Human Serum Albumin(HSA) Industrial Chain
8.2 Recombinant Human Serum Albumin(HSA) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Recombinant Human Serum Albumin(HSA) Sales Model
8.5.2 Sales Channel
8.5.3 Recombinant Human Serum Albumin(HSA) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Recombinant Human Serum Albumin(HSA) Market Trends
Table 2. Recombinant Human Serum Albumin(HSA) Market Drivers & Opportunity
Table 3. Recombinant Human Serum Albumin(HSA) Market Challenges
Table 4. Recombinant Human Serum Albumin(HSA) Market Restraints
Table 5. Global Recombinant Human Serum Albumin(HSA) Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Recombinant Human Serum Albumin(HSA) Revenue Market Share by Company (2020-2025)
Table 7. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Recombinant Human Serum Albumin(HSA) Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Recombinant Human Serum Albumin(HSA) Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Recombinant Human Serum Albumin(HSA) Manufacturing Base and Headquarters
Table 11. Key Manufacturers Recombinant Human Serum Albumin(HSA) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Human Serum Albumin(HSA)
Table 13. Global Recombinant Human Serum Albumin(HSA) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin(HSA) as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Serum Albumin(HSA) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Recombinant Human Serum Albumin(HSA) Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Recombinant Human Serum Albumin(HSA) Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Value by Type (2020-2025)
Table 20. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Value by Type (2026-2031)
Table 21. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Recombinant Human Serum Albumin(HSA) Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Recombinant Human Serum Albumin(HSA) Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Recombinant Human Serum Albumin(HSA) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Recombinant Human Serum Albumin(HSA) Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Recombinant Human Serum Albumin(HSA) Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Value by Application (2020-2025)
Table 32. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Value by Application (2026-2031)
Table 33. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Recombinant Human Serum Albumin(HSA) Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Recombinant Human Serum Albumin(HSA) Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Recombinant Human Serum Albumin(HSA) Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Recombinant Human Serum Albumin(HSA) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (2020-2025) & (%)
Table 44. Global Recombinant Human Serum Albumin(HSA) Sales Value by Region (2026-2031) & (%)
Table 45. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (2020-2025) & (%)
Table 49. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Region (2026-2031) & (%)
Table 50. Global Recombinant Human Serum Albumin(HSA) Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Recombinant Human Serum Albumin(HSA) Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Volume, (2026-2031) & (K Units)
Table 57. Merck Company Information
Table 58. Merck Introduction and Business Overview
Table 59. Merck Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Merck Recombinant Human Serum Albumin(HSA) Product Offerings
Table 61. Merck Recent Development
Table 62. MP Biomedicals Company Information
Table 63. MP Biomedicals Introduction and Business Overview
Table 64. MP Biomedicals Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. MP Biomedicals Recombinant Human Serum Albumin(HSA) Product Offerings
Table 66. MP Biomedicals Recent Development
Table 67. Proteintech Company Information
Table 68. Proteintech Introduction and Business Overview
Table 69. Proteintech Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Proteintech Recombinant Human Serum Albumin(HSA) Product Offerings
Table 71. Proteintech Recent Development
Table 72. InVitria Company Information
Table 73. InVitria Introduction and Business Overview
Table 74. InVitria Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. InVitria Recombinant Human Serum Albumin(HSA) Product Offerings
Table 76. InVitria Recent Development
Table 77. Sino Biological Company Information
Table 78. Sino Biological Introduction and Business Overview
Table 79. Sino Biological Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Sino Biological Recombinant Human Serum Albumin(HSA) Product Offerings
Table 81. Sino Biological Recent Development
Table 82. Reprokine Company Information
Table 83. Reprokine Introduction and Business Overview
Table 84. Reprokine Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Reprokine Recombinant Human Serum Albumin(HSA) Product Offerings
Table 86. Reprokine Recent Development
Table 87. ACROBiosystems Company Information
Table 88. ACROBiosystems Introduction and Business Overview
Table 89. ACROBiosystems Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. ACROBiosystems Recombinant Human Serum Albumin(HSA) Product Offerings
Table 91. ACROBiosystems Recent Development
Table 92. Assay Genie Company Information
Table 93. Assay Genie Introduction and Business Overview
Table 94. Assay Genie Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Assay Genie Recombinant Human Serum Albumin(HSA) Product Offerings
Table 96. Assay Genie Recent Development
Table 97. Cell Biologics Company Information
Table 98. Cell Biologics Introduction and Business Overview
Table 99. Cell Biologics Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Cell Biologics Recombinant Human Serum Albumin(HSA) Product Offerings
Table 101. Cell Biologics Recent Development
Table 102. Sartorius AG Company Information
Table 103. Sartorius AG Introduction and Business Overview
Table 104. Sartorius AG Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Sartorius AG Recombinant Human Serum Albumin(HSA) Product Offerings
Table 106. Sartorius AG Recent Development
Table 107. Yeasen Company Information
Table 108. Yeasen Introduction and Business Overview
Table 109. Yeasen Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Yeasen Recombinant Human Serum Albumin(HSA) Product Offerings
Table 111. Yeasen Recent Development
Table 112. MedChemExpress Company Information
Table 113. MedChemExpress Introduction and Business Overview
Table 114. MedChemExpress Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. MedChemExpress Recombinant Human Serum Albumin(HSA) Product Offerings
Table 116. MedChemExpress Recent Development
Table 117. Abcam Company Information
Table 118. Abcam Introduction and Business Overview
Table 119. Abcam Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Abcam Recombinant Human Serum Albumin(HSA) Product Offerings
Table 121. Abcam Recent Development
Table 122. Basic Pharma Company Information
Table 123. Basic Pharma Introduction and Business Overview
Table 124. Basic Pharma Recombinant Human Serum Albumin(HSA) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Basic Pharma Recombinant Human Serum Albumin(HSA) Product Offerings
Table 126. Basic Pharma Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Recombinant Human Serum Albumin(HSA) Downstream Customers
Table 130. Recombinant Human Serum Albumin(HSA) Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Serum Albumin(HSA) Product Picture
Figure 2. Global Recombinant Human Serum Albumin(HSA) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Recombinant Human Serum Albumin(HSA) Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Recombinant Human Serum Albumin(HSA) Sales Volume (2020-2031) & (K Units)
Figure 5. Global Recombinant Human Serum Albumin(HSA) Sales Price (2020-2031) & (US$/Unit)
Figure 6. Recombinant Human Serum Albumin(HSA) Report Years Considered
Figure 7. Global Recombinant Human Serum Albumin(HSA) Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Recombinant Human Serum Albumin(HSA) Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Serum Albumin(HSA) Revenue in 2024
Figure 10. Recombinant Human Serum Albumin(HSA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Yeast Expression System Picture
Figure 12. Mammalian Cell Expression System Picture
Figure 13. Plant Expression System Picture
Figure 14. Insect Cell Expression System Picture
Figure 15. Global Recombinant Human Serum Albumin(HSA) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Recombinant Human Serum Albumin(HSA) Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Recombinant Human Serum Albumin(HSA) Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Recombinant Human Serum Albumin(HSA) Price by Type (2020-2031) & (US$/Unit)
Figure 20. Product Picture of Biopharmaceuticals
Figure 21. Product Picture of Cell Culture & Regenerative Medicine
Figure 22. Product Picture of In Vitro Diagnostics
Figure 23. Product Picture of Others
Figure 24. Global Recombinant Human Serum Albumin(HSA) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 25. Global Recombinant Human Serum Albumin(HSA) Sales Value Market Share by Application, 2024 & 2031
Figure 26. Global Recombinant Human Serum Albumin(HSA) Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 27. Global Recombinant Human Serum Albumin(HSA) Sales Volume Market Share by Application, 2024 & 2031
Figure 28. Global Recombinant Human Serum Albumin(HSA) Price by Application (2020-2031) & (US$/Unit)
Figure 29. North America Recombinant Human Serum Albumin(HSA) Sales Value (2020-2031) & (US$ Million)
Figure 30. North America Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
Figure 31. Europe Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
Figure 33. Asia Pacific Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Recombinant Human Serum Albumin(HSA) Sales Value by Region (%), 2024 VS 2031
Figure 35. South America Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 36. South America Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
Figure 37. Middle East & Africa Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 38. Middle East & Africa Recombinant Human Serum Albumin(HSA) Sales Value by Country (%), 2024 VS 2031
Figure 39. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Value (%), (2020-2031)
Figure 40. Key Countries/Regions Recombinant Human Serum Albumin(HSA) Sales Volume (%), (2020-2031)
Figure 41. United States Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 42. United States Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 43. United States Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 44. Europe Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 45. Europe Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 46. Europe Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 47. China Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 48. China Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 49. China Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 50. Japan Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 51. Japan Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 52. Japan Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 53. South Korea Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 54. South Korea Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 55. South Korea Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 56. Southeast Asia Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 57. Southeast Asia Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 58. Southeast Asia Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 59. India Recombinant Human Serum Albumin(HSA) Sales Value, (2020-2031) & (US$ Million)
Figure 60. India Recombinant Human Serum Albumin(HSA) Sales Value by Type (%), 2024 VS 2031
Figure 61. India Recombinant Human Serum Albumin(HSA) Sales Value by Application (%), 2024 VS 2031
Figure 62. Recombinant Human Serum Albumin(HSA) Industrial Chain
Figure 63. Recombinant Human Serum Albumin(HSA) Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Recombinant Human Serum Albumin(HSA) market?
The top companies in the global Recombinant Human Serum Albumin(HSA) market are Merck、MP Biomedicals、Proteintech.
What is the annual compound growth rate of the global Recombinant Human Serum Albumin(HSA) market size from 2025 to 2031?
What was the global market size of Recombinant Human Serum Albumin(HSA) in 2025?
What was the global market size of Recombinant Human Serum Albumin(HSA) in 2031?
Which region is expected to have the highest market share?
Related Reports
Global Recombinant Human Serum Albumin(HSA) Market Research Report 2025
The global market for Recombinant Human Serum Albumin(HSA) was valued at US$ 102 million in the year 2024 and is projected to reach a revised size of US$ 217 million by 2031, growing at a CAGR of 10.5% during the forecast period.
Published Date: 2025-05-23
Pages: 92
USD 2900.00
(Single User License)
Global Recombinant Human Serum Albumin(HSA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Serum Albumin(HSA) market size was US$ 102 million in 2024 and is forecast to a readjusted size of US$ 217 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.
Published Date: 2025-05-23
Pages: 95
USD 4250.00
(Single User License)
Global Recombinant Human Serum Albumin(HSA) Market Insights, Forecast to 2031
The global Recombinant Human Serum Albumin(HSA) market is projected to grow from US$ 119 million in 2025 to US$ 217 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.5% during the forecast period.
Published Date: 2025-05-23
Pages: 164
USD 4900.00
(Single User License)
Global Recombinant Human Serum Albumin(HSA) Market Research Report 2025
The global market for Recombinant Human Serum Albumin(HSA) was valued at US$ 102 million in the year 2024 and is projected to reach a revised size of US$ 217 million by 2031, growing at a CAGR of 10.5% during the forecast period.
Published: 2025-05-23
Pages: 92
USD 2900.00 (Single User License)Global Recombinant Human Serum Albumin(HSA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human Serum Albumin(HSA) market size was US$ 102 million in 2024 and is forecast to a readjusted size of US$ 217 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.
Published: 2025-05-23
Pages: 95
USD 4250.00 (Single User License)Global Recombinant Human Serum Albumin(HSA) Market Insights, Forecast to 2031
The global Recombinant Human Serum Albumin(HSA) market is projected to grow from US$ 119 million in 2025 to US$ 217 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.5% during the forecast period.
Published: 2025-05-23
Pages: 164
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now